Literature DB >> 8312497

Inner clot diffusion and permeation during fibrinolysis.

S L Diamond1, S Anand.   

Abstract

A model of fibrinolysis was developed using multicomponent convection-diffusion equations with homogeneous reaction and heterogeneous adsorption and reaction. Fibrin is the dissolving stationary phase and plasminogen, tissue plasminogen activator (tPA), urokinase (uPA), and plasmin are the soluble mobile species. The model is based on an accurate molecular description of the fibrin fiber and protofibril structure and contains no adjustable parameters and one phenomenological parameter estimated from experiment. The model can predict lysis fronts moving across fibrin clots (fine or coarse fibers) of various densities under different administration regimes using uPA and tPA. We predict that pressure-driven permeation is the major mode of transport that allows for kinetically significant thrombolysis during clinical situations. Without permeation, clot lysis would be severely diffusion limited and would require hundreds of minutes. Adsorption of tPA to fibrin under conditions of permeation was a nonequilibrium process that tended to front load clots with tPA. Protein engineering efforts to design optimal thrombolytics will likely be affected by the permeation processes that occur during thrombolysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8312497      PMCID: PMC1226003          DOI: 10.1016/S0006-3495(93)81314-6

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  37 in total

1.  Mass-length ratio of fibrin fibers from gel permeation and light scattering.

Authors:  M E Carr; L L Shen; J Hermans
Journal:  Biopolymers       Date:  1977-01       Impact factor: 2.505

2.  The effect of fibrin structure on fibrinolysis.

Authors:  D A Gabriel; K Muga; E M Boothroyd
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

3.  The effect of plasmin on the subunit structure of human fibrin.

Authors:  S V Pizzo; M L Schwartz; R L Hill; P A McKee
Journal:  J Biol Chem       Date:  1973-07-10       Impact factor: 5.157

4.  Fibrin gel structure and clotting time.

Authors:  B Blombäck; M Okada
Journal:  Thromb Res       Date:  1982 Jan 1-15       Impact factor: 3.944

5.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

Authors:  M Hoylaerts; D C Rijken; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

Review 6.  Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates.

Authors:  R Lottenberg; U Christensen; C M Jackson; P L Coleman
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

7.  The binding of human plasminogen to fibrin and fibrinogen.

Authors:  M A Lucas; L J Fretto; P A McKee
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

8.  Size and density of fibrin fibers from turbidity.

Authors:  M E Carr; J Hermans
Journal:  Macromolecules       Date:  1978 Jan-Feb       Impact factor: 5.985

9.  Penetration of macromolecules into contracted blood clot.

Authors:  S P Domogatsky
Journal:  Biophys J       Date:  1992-09       Impact factor: 4.033

10.  Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.

Authors:  E Suenson; S Thorsen
Journal:  Biochem J       Date:  1981-09-01       Impact factor: 3.857

View more
  45 in total

1.  High mortality associated with intracardiac and intrapulmonary thromboses after cardiopulmonary bypass.

Authors:  Satoru Ogawa; James E Richardson; Tetsuro Sakai; Masahiro Ide; Kenichi A Tanaka
Journal:  J Anesth       Date:  2011-10-19       Impact factor: 2.078

2.  Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively.

Authors:  Mikhail A Panteleev; Mikhail V Ovanesov; Dmitrii A Kireev; Aleksei M Shibeko; Elena I Sinauridze; Natalya M Ananyeva; Andrey A Butylin; Evgueni L Saenko; Fazoil I Ataullakhanov
Journal:  Biophys J       Date:  2005-12-02       Impact factor: 4.033

3.  Kinetic model facilitates analysis of fibrin generation and its modulation by clotting factors: implications for hemostasis-enhancing therapies.

Authors:  Alexander Y Mitrophanov; Alisa S Wolberg; Jaques Reifman
Journal:  Mol Biosyst       Date:  2014-07-29

4.  Ultrasound-Enhanced Thrombolysis: EKOS EndoWave Infusion Catheter System.

Authors:  Charles A Owens
Journal:  Semin Intervent Radiol       Date:  2008-03       Impact factor: 1.513

5.  Circulatory concentrations of fibrinolytic species during thrombolytic therapy estimated by stirred-tank reactor analysis.

Authors:  V V Tuliani; E A O'Rear
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

6.  Elastic behavior and platelet retraction in low- and high-density fibrin gels.

Authors:  Adam R Wufsus; Kuldeepsinh Rana; Andrea Brown; John R Dorgan; Matthew W Liberatore; Keith B Neeves
Journal:  Biophys J       Date:  2015-01-06       Impact factor: 4.033

7.  The hydraulic permeability of blood clots as a function of fibrin and platelet density.

Authors:  A R Wufsus; N E Macera; K B Neeves
Journal:  Biophys J       Date:  2013-04-16       Impact factor: 4.033

8.  Intracisternal administration of tissue plasminogen activator improves cerebrospinal fluid flow and cortical perfusion after subarachnoid hemorrhage in mice.

Authors:  Dominic A Siler; Jorge A Gonzalez; Ruikang K Wang; Justin S Cetas; Nabil J Alkayed
Journal:  Transl Stroke Res       Date:  2014-02-14       Impact factor: 6.829

9.  Individual lytic efficacy of recombinant tissue plasminogen activator in an in vitro human clot model: rate of "nonresponse".

Authors:  Jason M Meunier; Evan Wenker; Christopher J Lindsell; George J Shaw
Journal:  Acad Emerg Med       Date:  2013-05       Impact factor: 3.451

10.  Blood flow controls coagulation onset via the positive feedback of factor VII activation by factor Xa.

Authors:  Alexey M Shibeko; Ekaterina S Lobanova; Mikhail A Panteleev; Fazoil I Ataullakhanov
Journal:  BMC Syst Biol       Date:  2010-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.